Kedrion Biopharma and InstaLILY to Host Healthcare AI Innovation Summit at NY Tech Week

June 01, 2026
Kedrion Biopharma and InstaLILY will co-host the Rare Connections: Healthcare AI Innovation Summit on June 3 during NY Tech Week, bringing together leaders from pharma, technology, and research to discuss the practical use of AI in healthcare.
Kedrion Biopharma and InstaLILY to Host Healthcare AI Innovation Summit at NY Tech Week

Kedrion Biopharma and InstaLILY will co-host the Rare Connections: Healthcare AI Innovation Summit on June 3 as part of NY Tech Week, announced in a press release. The invitation-only event will gather leaders from the pharmaceutical, technology, investment, and research sectors to explore how organizations are implementing artificial intelligence across healthcare.

The half-day summit will include sessions on clinical development, commercial operations, specialty pharmacies, investment strategy, and responsible technology adoption. Discussions will focus on how AI is being used to improve decision making, patient access, and healthcare outcomes.

Speakers will include representatives from Google DeepMind, Bain Capital Private Equity, Kedrion Biopharma, InstaLILY AI, Insight Partners, and other organizations. The event aims to highlight practical examples of AI adoption that enhance operational efficiency and patient experiences.

The summit will take place on June 3 in New York during NY Tech Week. Interested participants can request to join the waitlist through the event website.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

06/01
AssureCare Introduces NutraVance Nutrition Platform for Population Health
06/01
Conscientia Health Launches Clinician Driven AI Platform for Mental Health
06/01
3billion Launches Genomic Newborn Screening Service 3B-NEO
06/01
GRAIL Reports NHS Galleri Trial Results Showing Fewer Stage IV Cancer Diagnoses
05/29
Nucs AI and AstraZeneca Collaborate on AI Response Prediction for Radioconjugate Research

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like